Full-Time

Software Engineer – New Grad

Confirmed live in the last 24 hours

Genesis Therapeutics

Genesis Therapeutics

51-200 employees

AI-driven drug discovery for pharmaceuticals

AI & Machine Learning
Biotechnology

Entry

Burlingame, CA, USA

Hybrid position in Burlingame, CA.

Category
Backend Engineering
Full-Stack Engineering
Software Engineering
Requirements
  • A deep thinker who reasons from first principles, balances attention to detail with architectural thinking, and has an investigational curiosity to find the root cause of a problem
  • Comfortable working across all levels of the software stack, from front-end interfaces to backend features to managing infrastructure
  • Have experience writing production code and driving internship and school projects to completion
  • Interested in learning more about drug discovery and machine learning
Responsibilities
  • Build and expand on tools for visualizing molecules and proteins, analyzing machine learning models, and managing complex chemical workflows
  • Work closely with machine learning engineers and medicinal chemists to develop and productionize new computational methods for molecular property prediction
  • Help scale our data infrastructure to handle billions of datapoints and thousands of parallel deep learning and molecular dynamics jobs

Genesis Therapeutics uses artificial intelligence to accelerate the development of new medicines in the pharmaceutical industry. By combining 3D spatial graph modeling and molecular simulation, the company generates potential drug candidates and explores new chemical spaces. Unlike its competitors, Genesis focuses on strategic partnerships with other biotech firms, exemplified by its deal with Eli Lilly, which includes significant upfront and potential future payments. The goal is to discover critical new medicines through these collaborations.

Company Stage

Series B

Total Funding

$272.5M

Headquarters

Burlingame, California

Founded

2019

Growth & Insights
Headcount

6 month growth

20%

1 year growth

52%

2 year growth

148%
Simplify Jobs

Simplify's Take

What believers are saying

  • Partnership with NVIDIA enhances GEMS platform for targeting undruggable diseases.
  • $224 million equity investment boosts research and development capabilities.
  • Recognition as a 'Fierce 15' company underscores AI's role in breakthrough therapeutics.

What critics are saying

  • Competition from AI-driven companies like Insilico Medicine and Exscientia is increasing.
  • Over-reliance on partnerships could lead to financial instability if drugs aren't successful.
  • Rapid AI advancements may render current models like GEMS obsolete without updates.

What makes Genesis Therapeutics unique

  • Genesis Therapeutics uses AI to accelerate drug discovery with 3D spatial graph modeling.
  • The GEMS platform integrates deep learning, molecular simulations, and generative AI for drug design.
  • Strategic partnerships with Eli Lilly and Gilead highlight Genesis' industry collaboration strength.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive salary

Equity

Medical, dental, & vision insurance

401(k) program